Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Auditor change
Director departure
JUNIPER PHARMACEUTICALS INC (JNP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/31/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2018 EFFECT Form EFFECT - Notice of Effectiveness:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/14/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/14/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Juniper Pharmaceuticals, Inc",
"Amended and Restated Bylaws of Juniper Pharmaceuticals, Inc"
08/14/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/14/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/09/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/09/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results Signs Agreement to be Acquired by Catalent, Inc. CRINONE ® Revenues Increased 12% and Juniper Pharma Services Revenues Increased 41% for the Six-months Ended June 30, 2018 vs. Prior Year"
08/06/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/31/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy